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Abstract 
BACKGROUND: The use of albumin in the critical care setting is a very controversial issue. Low serum albumin 
concentration in critical illness is associated with a poor outcome.  
AIM: We aimed to evaluate the influence of albumin level in critically ill children to the length of stay and mortality 
in the Pediatric Intensive Care Unit (PICU) Haji Adam Malik General Hospital, Medan, Indonesia.  
METHODS: The study used an observational method with a cross-sectional design. The population of the study 
was all patients with major postoperative surgery and critically ill that admitted to the PICU at Haji Adam Malik 
Hospital from the period of June 2008 to September 2008. The albumin level of the subjects was determined on 
the first day admitted.  
RESULTS: The group with hypoalbuminemia (< 3 g/dL) was given albumin supplementation according to a 
protocol in the PICU. The group with hypoalbuminemia have an average length of stay 7.6 days (9.7%) and 
mortality of 12 subjects (36.4%). The group with normal albumin level have 4.7 days (5.0%) and mortality 13 
subjects (37.1%). There was no significant effect of albumin level to mortality.  
CONCLUSION: Albumin level did not affect the length of stay and mortality in PICU. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Albumin is a protein produced in the liver 
which plays a role in blood oncotic pressure. Besides, 
in colloid osmotic pressure, albumin also works as a 
transport molecule for bilirubin, fatty acids, and 
medications [1].
 
The role of albumin in critical illness is not 
fully understood. There are significant differences in 
the role of albumin between healthy and critically ill 
children. Low serum albumin concentrations in 
critically ill patients are associated with poor outcomes 
[2], [3], [4]. In healthy individuals, albumin act to 
maintain Colloid Osmotic Pressure (COP) but is less 
correlated in critically ill individuals [4]. Patient with a 
critical illness has a low COP. Among 200 patients, 
those with critical illness had a COP of 19.1 mmHg. 
Low colloid osmotic pressure correlates with high 
morbidity and mortality in critically ill patients. The 
COP of 15 mmHg is associated with a 50% life 
expectancy. Administration of albumin 
supplementation will increase COP and prevent fatal 
complications such as pulmonary oedema, which in 
turn, develop into respiratory failure [3], [4].
 
The osmotic pressure can be directly 
measured using oncometers or Van't Hoff equation: 
osmotic pressure = nx (c / M) x RT, where n = number 
of particles in the substrate (n = 1 for plasma 
proteins), c / M = molar concentration of the substrate, 
R = constant of 0.082, T = absolute temperature [5].
 
Based on a descriptive study of 134 children 
with critical illness in the pediatric intensive care unit 
(PICU), the incidence of hypoalbuminemia before 
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admission was 57% and may increase to 76% in the 
first 24 hours [6].  
Hypoalbuminemia often occurs in critical 
illness. The causes of hypoalbuminemia are complex 
and affected by various mechanisms such as the 
imbalance between albumin production and 
destruction, increased capillary permeability, and 
altered intravascular and extravascular albumin 
distribution [2], [4]. 
The relationship between hypoalbuminemia 
and poor outcomes has motivated clinicians to provide 
exogenous albumin in patients with hypoalbuminemia. 
Although hypoalbuminemia directly leads to a poor 
outcome, there is still controversy about this [4]. 
 
 
Material and Methods 
 
This study used an observational method with 
a cross-sectional design. The study was conducted at 
Haji Adam Malik General Hospital from June 2008 to 
September 2008. 
The subjects of the study were all patients 
admitted to PICU at Haji Adam Malik General 
Hospital, Medan, Indonesia, from the period of June 
2008 to September 2008. The subjects were taken 
with the purposive sampling method.  
The inclusion criteria included major post-
operative surgery and critically ill, while the exclusion 
criteria included multiple congenital anomalies, post-
operative surgery patient with length of stay less than 
24 hours, burn patient and those who refuse to take 
part in the study. 
The variables being studied include 1) 
albumin level in the first day admitted; 2) length of 
stay; 3) mortality; and 4) type of cases, with 
classification surgery or non-surgery case. 
Before the research was carried out, ethical 
clearance was sought and approved by the Ethics 
Committee of Universitas Sumatera Utara Medical 
Faculty. 
 
 
Results 
 
From this study, of 68 subjects in the PICU, 
there were 33 patients with hypoalbuminemia (48.5%) 
and 35 (51.4%) with normal albumin level. From the 
two groups, the mean albumin level was 3.05 g/dL 
(0.749), with the lowest levels of 1.5 g/dL and the 
highest at 4.7 g/dL. The mean albumin level was 2.33 
g/dL in hypoalbuminemia group and 3.62 g/dL in 
normal albumin group with P = 0.001 (Table 1). 
Table 1: The characteristics of subjects in both study groups 
Parameter Hypoalbuminemia (n = 33) Normal albumin (n = 35) 
Albumin level (g/dL), 
mean (SD) 
2.33 
(0.40) 
3.61 
(0.44) 
Gender, n (%)  
Male 
Female 
 
23 (69.7) 
10 (30.3) 
 
24 (68.6) 
11 (31.4) 
Age (months) 
mean (SD) 
53.3 
(49.9) 
53.1 
(48.8) 
Weight (Kg) 
mean (SD) 
15.6 
(13.13) 
14.8 
(9.55) 
Eid index, n (%) 
< 70 
70-80 
80-90 
90-110 
110-120 
> 120 
 
9 (27.3) 
3 (9.10) 
6 (18.2) 
10 (30.3) 
3 (9.10) 
2 (6.10) 
 
11 (31.4) 
7 (20.0) 
7 (20.0) 
7 (20.0) 
2 (5.70) 
1 (2.90) 
Type of cases, n (%) 
Surgical  
Non-surgical 
 
21 (63.6) 
12 (36.4) 
 
19 (54.3) 
16 (45.7) 
 
This study showed that there was a higher 
proportion of male than female. In the 
hypoalbuminemia group, the proportion of male 
patients was 69.7%, and female patients were 30.3%, 
whereas in the normal albumin group, the number of 
male patients was 68.6% and female patients were 
31.4%. 
Furthermore, the mean age, weight, and 
nutritional status, in this case, were assessed by EID 
index and type of case (surgical or non-surgical) 
between the two groups did not show significant 
differences. 
In this study (Table 2), we also found that the 
hypoalbuminemia group needs longer treatment (7.6 
days) compared to the normal albumin group (4.7 
days).  
Table 2: The relationship between albumin levels and length of 
stay and mortality 
Parameter 
Hypo- albuminemia  
(n = 33) 
Normal albumin  
(n = 35) 
P 
Length of stay (days); mean (SD) 
 
7.6 (9.77) 
 
4.7 (5.0) 
0.134 
Mortality, n (%)  
Yes 
No 
 
12 (36.4) 
21 (63.6) 
 
13 (37.1) 
22 (62.9) 
0.947 
 
This is different from the results of this study 
where the patients were not distinguished whether as 
surgical and non-surgical cases, and it was found that 
there was higher mortality in the normal albumin 
group (37.1%) than the hypoalbuminemia group 
(36.4%) although both were not significantly different. 
Table 3: The results of multivariate analysis of length of stay 
Variable B P 95% CI 
Albumin level -3.502 0.049 -6.984; -0.020 
Type of cases 6.424 0.001 -2.838; 10.010 
Nutritional status -0.146 0.808 -1.339; 1.047 
 
In this study (Table 3 and Table 4), nutritional 
status had no significant association with length of 
stay and mortality, but the types of cases, whether 
surgical or non-surgical had a significant association 
with length of stay and mortality (P = 0.001). From 
Table 3, the results of multivariate analysis showed 
that the variables with the greatest contribution to the 
length of stay were the types of cases. 
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Table 4: The results of the multivariate analysis of mortality 
Variable B P 95% CI 
Albumin level 0.371 0.540 0.442; 4.775 
Type of cases -2.093 0.001 0.038; 0.403 
Nutritional status 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
 
-6.73 
-2.38 
-0.378 
0.677 
0.734 
2.331 
0.816 
0.621 
0.758 
0.654 
0.450 
0.430 
0.322 
 
0.035; 7.338 
0.174; 3.578 
0.110; 3.577 
0.340; 11.40 
0.205; 3.511 
0.123; 4.712 
 
 
 
Discussion  
 
Albumin has several physiological functions 
and has been used extensively in the field of 
anaesthesia and intensive care as indicated. After 
more than 60 years of clinical research, administration 
of albumin is still questionable. In critically ill patients, 
several pathophysiological processes such as 
infection, trauma, or major surgery result in an 
inflammatory process that eventually releases 
mediators such as cytokines and leukocyte activation. 
This will result in disruption of endothelial function, 
increased microvascular permeability, and 
extravasation of fluid (including albumin) to the tissue. 
Acute-phase proteins, produced by the liver, are the 
sign of inflammation that is used to evaluate the 
relationship between hypoalbuminemia and poor 
outcomes [7], [8]. 
A prospective study of routine nutritional 
laboratory parameters examined less than 24 hours in 
105 severely ill children in intensive care unit found a 
prevalence of hypomagnesaemia 20%, 
hypertriglyceridemia 25%, uremia 30%, and 
hypoalbuminemia 52% [9]. 
Hypoalbuminemia is a marker of morbidity 
and mortality in children with a critical illness. A 
retrospective study comparing groups of patients with 
hypoalbuminemia and groups with normal albumin 
levels in patients in the PICU showed that in the 
hypoalbuminemia group, the length of stay in PICU 
was longer (8.1 days) compared to those with normal 
albumin levels (4.4 days). The hypoalbuminemia 
group has a lower life expectancy and a higher rate of 
organ failure [10].
 
A study of cardiac and non-cardiac surgery 
patients and kidney impairment found that 
hypoalbuminemia was a predictor of poor outcome, 
where each 10 g/dL decrease in serum albumin would 
increase the mortality odds by 137%, morbidity by 
89%, length of stay in the intensive care unit and 
hospital care by 28% and 71%, respectively [11]. 
Hypoalbuminemia is the result of a 
combination of inflammation and inadequate caloric 
input in patients with chronic renal failure. 
Inflammation and malnutrition will reduce the 
synthesis and increase protein catabolism which may 
reduce albumin concentration [12]. 
Transcapillary albumin excretion increased by 
300% in patients with septic shock and by 100% after 
cardiac surgery. In septic patients, transcapillary 
changes will occur if appropriate treatment is 
administered. With increased albumin flow through the 
capillary membrane, there is an increase in lymphatic 
return to the intravascular space. Albumin movement 
during major surgery shows a decrease in lymphatic 
flow and albumin concentration in the lymphatic 
vessels. Measurements of total circulation and 
albumin exchange showed a 30% reduction with 
major surgery (Nicholson, 2000). In a prospective 
study, serum albumin was shown as a predictor of the 
outcome of postoperative patients [13]. 
A Cochrane Collaboration study concluded 
that there is no evidence which showed that albumin 
reduces mortality in patients with hypovolemia 
compared to cheaper alternatives such as normal 
saline and in critically ill patients with burns or 
hypoalbuminemia [14]. 
In this study, according to the intensive care 
unit protocol, all patients in the hypoalbuminemia 
group received albumin substitution as needed. 
Hypoalbuminemia is a frequent phenomenon in critical 
illness. Treatment focuses on the main causes of 
hypoalbuminemia rather than administering albumin. 
The results of several meta-analyses of albumin 
administration in hospitalised patients were 
inconsistent [15].
 
The role of albumin in critically ill patients is 
not supported by scientific evidence. 
Hypoalbuminemia correction does not have a 
significant advantage; treatment is aimed at basic 
diseases to treat hypoalbuminemia [13]. Albumin is 
recommended according to the appropriate 
indications for patients in the intensive care unit [8].
 
Intravenous albumin is appropriate for 
patients with cirrhosis with ascites, kidney failure, and 
hepatorenal syndrome awaiting liver transplantation. 
In patients with nephrotic syndrome who do not 
respond to standard therapy, severe symptomatic 
hypovolemia, administration of intravenous albumin 
and diuretics might be considered [16]. From an in-
vitro study of sepsis patients, it was shown that 
albumin administration did not affect vascular 
permeability. The administration of 200 ml of 20% 
albumin was not significant in reducing microvascular 
protein leakage [17]. From a review of a randomised 
clinical study, administering low dose hyperoncotic 
albumin for hypovolemic resuscitation has several 
advantages such as reducing morbidity, renal 
impairment, and oedema [18].
 
Addition of albumin in parenteral nutrition 
solutions is also not recommended. It is said that fatal 
complications may occur compared to its benefits. 
Possible complications include infection, 
incompatibility, and chemical and physical instability 
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[19]. It was stated that the administration of albumin 
would cause a decrease in life expectancy in patients 
with critical illness [20]. This is in contrast to a study of 
a meta-analysis of randomised controlled trials that 
did not find the effect of albumin on mortality [21].
 
The study also found no difference between 
the hypoalbuminemia and normal albumin groups to 
mortality (P = 0.947). Based on previous studies and 
based on the results of our study, albumin levels do 
not affect the length of stay and mortality of patients in 
the intensive care unit. 
In this study, there was no effect of albumin 
levels on the length of stay and mortality of patients in 
the pediatric intensive care unit. The type of cases 
has a significant association in the length of stay and 
mortality. 
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